Sudden Cardiac Death: Definitions

Size: px
Start display at page:

Download "Sudden Cardiac Death: Definitions"

Transcription

1 Contemporary Epidemiology of Sudden Death: Insights from the Comprehensive UCSF SCD Study 23 October 2010 Update in Electrocardiography and Arrhythmias Zian H. Tseng, M.D., M.A.S. Assistant Professor of Medicine Electrophysiology Section University of California, San Francisco Disclosures Major Research grant: NIH K12 RR Research grant: NIH/NHLBI R01 HL Minor Biotronik: Honorarium St. Jude Medical: Honorarium Sudden Death: Background 1/3 of SCA events are unwitnessed Impossible to restrict the definition of SCA to documented VF since rhythm at clinical presentation is unknown in many cases Operational criteria for SCA and SCD do not rely upon the cardiac rhythm at the time of the event Duration of symptoms (< 1 hr) prior to SCA generally defines the suddenness of death 1

2 Sudden Death: Definitions Out-of-hospital occurrence of a presumed sudden pulseless condition in the absence of evidence of a noncardiac condition (e.g., pulmonary, CVA, PE) as the cause of collapse WHO definition of SCD: Unexpected death within 1 h of symptom onset if witnessed Unexpected death within 24 h of having been observed alive and sx-free if unwitnessed Magnitude of Sudden Death in the U.S. 1 U.S. Census Bureau, Statistical Abstract of the United States: American Cancer Society, Inc., Surveillance Research, Cancer Facts and Figures Heart and Stroke Statistical Update, American Heart Association. 4 Circulation. 2001;104: SCD Rates in the Developed World 2

3 Etiology of Sudden Death Huikuri et al. N Engl J Med, Vol Surveillance of SCD in San Francisco County San Francisco County: 2007 population 756,976 Median age 36.5 years 49% female: 51% male 31% Asian, 8% Black, 44% Caucasian, 14% Hispanic/Latino By California state law, all out-of-hospital have to be reported to ME All cases without an attending physician willing or able to determine cause of death (i.e. ER deaths) are reported to ME Retrospective review of all ME death records for deaths meeting WHO SCD definition to determine incidence of SCD in 2007 Cases were excluded if : known history of non-cardiac chronic and/or terminal illness identifiable non-cardiac etiology at time of death (e.g., obvious recent drug use). Retrospective Review of all ME Deaths, SF 2007 Review of details of presentacon at death All SF ME Deaths N= 1420 WHO SCDs N=262 Tseng ZH, et al AHA Scientific Sessions

4 WHO SCDs in San Francisco County, 2007 Between January 1, 2007 and December 31, 2007: 262 cases of WHO SCD Incidence of 34.6 per 100,000 Previous estimates in homogeneous populations: /100,000 Mean age 61.3 years 30% female: 70% male 4.3% of overall mortality in San Francisco County 2007 SCD Rates in San Francisco County by Ethnicity Determination of Actual Sudden Arrhythmic Deaths How specific are WHO SCD criteria for actual arrhythmic sudden death? Panel of 3 physicians For each WHO SCD: review of all post-mortem ME investigations (prior hospital records, autopsy, toxicology, histology) Final cause of death adjudicated as Noncardiac (e.g. PE, CVA) non-arrhythmic sudden death (e.g., CHF, tamponade) sudden arrhythmic death 4

5 Determination of Sudden Arrhythmic Deaths Review of details of presentacon at death Review of full ME invescgacon (records, autopsy, toxicology) All SF ME Deaths N= 1420 WHO SCDs N=262 N=158 (60.3%) Non- N=104 (39.7%) Sudden Arrhythmic Death N=147 (56% of WHO SCDs) Non- Arrhythmic Sudden Death N=11 Tseng ZH, et al AHA Scientific Sessions 2009 Sudden Arrhythmic Death in San Francisco etiology accounted for 158 of 262 WHOdefined SCDs representing a rate of 20.9 per 100,000 Accuracy of WHO criteria for true cardiac etiology = 60.3% Accuracy of WHO criteria for arrhythmic etiology = 56.1% Most common non-cardiac causes of SCD were lethal drug or alcohol overdose, pulmonary disease, and cancer. Low PPV for True SAD WHO SCD SAD Cases Incidence (per 100,000) Mean Age Percent Male Overall Mortality (2007) 69.9% 70.1% 4.3% 2.4% Number of Cases WHO SCD v. SAD WHO SCD SAD PPV of WHO SCD criteria for true SAD = 56.1% Tseng ZH, et al AHA Scientific Sessions

6 140 SCD Rates in San Francisco, 2007 Rates of SCD per 100, SF 2007 WHO SCD SF 2007 SAD Chugh et al. (2004) de Vreede- Swagemakers Low Rate Becker et al. et al. (1997) (1993) High Rate Becker et al. (1993) 1. Chugh SS, Jui J, Gunson K, Stecker EC, John BT, Thompson B, Ilias N, Vickers C, Dogra V, Daya M, Kron J, Zheng ZJ, Mensah G, McAnulty J. Current burden of sudden cardiac death: mulcple source surveillance versus retrospeccve death cercficate- based review in a large U.S. community. J Am Coll Cardiol. 2004;44(6): de Vreede- Swagemakers JJ, Gorgels AP, Dubois- Arbouw WI, van Ree JW, et al. Out- of- hospital cardiac arrest in the 1990s " a populacon- based study in the Maastricht area on incidence, characterisccs and survival. J Am Coll Cardiol 1997;30(6): Becker, LB, Smith DW, Rhodes KV. Incidence of cardiac arrest: a neglected factor in evaluacng survival rates. Ann Emerg Med 1993;22(1): Tseng ZH et al AHA 2009 SCD/SAD Rates Vary Widely by Ethnicity and Sex Tseng ZH, et al AHA Scientific Sessions 2009 Sudden Arrhythmic Deaths vs. Control (Trauma) Deaths SF ME Deaths N=1420 WHO SCDs N=262 N=158 Non- N=104 Accidental Trauma deaths N=376 Autopsy N=238 Arrhythmic N=147 Non-arrhythmic N=11 Autopsy N=47 6

7 CAD in SADs vs. Controls Significant CAD was present in 39% of SADs and associated with higher SAD risk compared to control deaths (OR 2.58, 95% CI , p=0.026). Only 1 of 37 (2.7%) SADs and 0 of 192 controls had an active coronary lesion, p = 0.17 Interstitial Fibrosis in SADs vs. Trauma Controls 40x LV septum, trichrome stain 77yo AM trauma victim, minimal CAD 77yo AM SAD victim, minimal CAD Global interstitial fibrosis score 1.5-fold higher in SADs than controls, adjusted for age, sex, ethnicity, CAD level Epidemiologic Insights Thus Far WHO SCD criteria have a low PPV for SAD Blacks have 2.4-fold higher incidence of SAD than Caucasians Men have 2.3-fold higher incidence than women Active coronary lesion as the cause of SAD is far lower than previous estimates Significant CAD accounted for less than 40% of SADs, half of historical estimates Significant CAD still imparts a 2.5-fold higher risk of SAD Interstitial myocardial fibrosis is associated with SAD and may serve a useful risk stratifier Reflects contemporary epidemiology of SAD and CAD in a diverse community 7

8 Magnitude of Sudden Death in the U.S. 1 U.S. Census Bureau, Statistical Abstract of the United States: American Cancer Society, Inc., Surveillance Research, Cancer Facts and Figures Heart and Stroke Statistical Update, American Heart Association. 4 Circulation. 2001;104: Etiology of Sudden Death Adapted from Huikuri et al. N Engl J Med, Vol Sudden Arrhythmic Deaths vs. Control (Trauma) Deaths SF ME Deaths N=1420 WHO SCDs N=262 N=158 Non- N=104 Accidental Trauma deaths N=376 Autopsy N=238 Arrhythmic N=147 Non-arrhythmic N=11 Autopsy N=47 8

9 Comprehensive UCSF SCD Study 5 year study, collaboration with SF County ME 3 years of systematic autopsy evaluation of SCD compared to frequency-matched trauma controls Evaluation of morphometric parameters Heart weight LV septal thickness MV prolapse Evaluation of myocardial fibrosis Creation of DNA and cardiac tissue bank for future high-quality genetic and molecular studies Derive more accurate definition of SCD Inform policy for investigation of SCDs by MEs Acknowledgements UCSF EP Section Jeff Olgin Dan Steinhaus Dean Whiteman UCSF Epidemiology Stephen Hulley Eric Vittinghoff Feng Lin UCSF Program in Human Genetics Brad Aouizerat Ludmila Pawlikowska Annie Poon UCSF Genomic Resource in Atherosclerosis John Kane Mary Malloy Clive Pullinger SFFD/ SFGH Emergency Medicine Karl Sporer SF Medical Examiner s Office Ellen Moffatt Amy Hart UCSF Pathology Phil Ursell 9

Redefining Sudden Cardiac Death: Insights from the Comprehensive UCSF SCD Study

Redefining Sudden Cardiac Death: Insights from the Comprehensive UCSF SCD Study Redefining Sudden Cardiac Death: Insights from the Comprehensive UCSF SCD Study 8 September 2012 California Heart Rhythm Symposium Zian H. Tseng, M.D., M.A.S. Associate Professor of Medicine in Residence

More information

Role of Non-Implantable Defibrillators in the Management of Patients at High Risk for Sudden Cardiac Death

Role of Non-Implantable Defibrillators in the Management of Patients at High Risk for Sudden Cardiac Death Role of Non-Implantable Defibrillators in the Management of Patients at High Risk for Sudden Cardiac Death 29 October 2011 Update in Electrocardiography and Arrhythmias Zian H. Tseng, M.D., M.A.S. Associate

More information

Sudden Cardiac Death and Asians Disclosures

Sudden Cardiac Death and Asians Disclosures Sudden Cardiac Death and Asians Disclosures 7 February 2009 Asian Heart and Vascular Symposium None Zian H. Tseng, M.D., M.A.S. Assistant Professor of Medicine Cardiac Electrophysiology Section University

More information

DEGREE (if applicable)

DEGREE (if applicable) BIOGRAPHICAL SKETCH NAME: Chugh, Sumeet S., MD, FAHA, FHRS, FACC era COMMONS USER NAME (credential, e.g., agency login): chughs OMB No. 0925-0001/0002 (Rev. 08/12 Approved Through 8/31/2015) POSITION TITLE:

More information

Cardiac, Physiologic, and Real World Effects of Taser Use

Cardiac, Physiologic, and Real World Effects of Taser Use Cardiac, Physiologic, and Real World Effects of Taser Use 1 June 2017 Conducted Energy Device Meeting San Francisco Police Department Zian H. Tseng, M.D., M.A.S. Murray Davis Endowed Professor Associate

More information

Risk Stratification of Sudden Cardiac Death

Risk Stratification of Sudden Cardiac Death Risk Stratification of Sudden Cardiac Death Michael R Gold, MD, PhD Medical University of South Carolina Charleston, SC USA Disclosures: None Sudden Cardiac Death A Major Public Health Problem > 1/2 of

More information

Sudden Death in Athletes: What is the role of ECG Screening?

Sudden Death in Athletes: What is the role of ECG Screening? Sudden Death in Athletes: What is the role of ECG Screening? Byron K. Lee MD Professor of Medicine Director of EP Laboratory leeb@medicine.ucsf.edu Division of Cardiology Cardiac Electrophysiology Arrhythmias,

More information

Epidemiologic Methods in the Study of Sudden Cardiac Death

Epidemiologic Methods in the Study of Sudden Cardiac Death Epidemiologic Methods in the Study of Sudden Cardiac Death Clinical Epidemiology and Biostatistics Mahidol University Bangkok Ross J. Simpson Jr, MD, PhD Division of Cardiology University of North Carolina

More information

Sudden Cardiac Death

Sudden Cardiac Death Sudden Cardiac Death management challenges of a global problem Zayd A. Eldadah, MD, PhD Co-Director, Cardiac Electrophysiology, Washington Hospital Center Director, Cardiac Electrophysiology, Georgetown

More information

Sudden Cardiac Death in Korea : Epidemiology and Risk Factors

Sudden Cardiac Death in Korea : Epidemiology and Risk Factors Sudden Cardiac Death in Korea : Epidemiology and Risk Factors Seok-Min Kang, MD, Ph D. Director, Heart Failure & Cardiac Wellness Center, Professor, Division of Cardiology, Severance Cardiovascular Hospital,

More information

Ventricular Tachycardia Ablation. Saverio Iacopino, MD, FACC, FESC

Ventricular Tachycardia Ablation. Saverio Iacopino, MD, FACC, FESC Ventricular Tachycardia Ablation Saverio Iacopino, MD, FACC, FESC ü Ventricular arrhythmias, both symptomatic and asymptomatic, are common, but syncope and SCD are infrequent initial manifestations of

More information

Out-of-Hospital Cardiac Arrest in the 1990s: A Population-Based Study in the Maastricht Area on Incidence, Characteristics and Survival

Out-of-Hospital Cardiac Arrest in the 1990s: A Population-Based Study in the Maastricht Area on Incidence, Characteristics and Survival 1500 JACC Vol. 30, No. 6 SUDDEN DEATH Out-of-Hospital Cardiac Arrest in the 1990s: A Population-Based Study in the Maastricht Area on Incidence, Characteristics and Survival JACQUELINE J. M. DE VREEDE-SWAGEMAKERS,

More information

Out-of-hospital cardiac arrest-the relevance of heart failure. The Maastricht Circulatory Arrest Registry

Out-of-hospital cardiac arrest-the relevance of heart failure. The Maastricht Circulatory Arrest Registry European Heart Journal (2003) 24, 1204 1209 Out-of-hospital cardiac arrest-the relevance of heart failure. The Maastricht Circulatory Arrest Registry Anton P.M. Gorgels*, Claudia Gijsbers, Jacqueline de

More information

Ablation Should Not Be Used as Primary Therapy for Treatment of Patients with Atrial Fibrillation

Ablation Should Not Be Used as Primary Therapy for Treatment of Patients with Atrial Fibrillation Ablation Should Not Be Used as Primary Therapy for Treatment of Patients with Atrial Fibrillation 25 October 2008 Update in Electrocardiography and Arrhythmias Zian H. Tseng, M.D., M.A.S. Assistant Professor

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Tseng ZH, Hayward RM, Clark NM, et al. Sudden death in patients with cardiac implantable electronic devices. JAMA Intern Med. Published online June 22, 2015. doi:10.1001/jamainternmed.2015.2641.

More information

Zoll Medical--LifeVest:

Zoll Medical--LifeVest: Zoll Medical--LifeVest: Territory Manager: Sunny Brown Cell: (818) 916-6520 Objectives Why the LifeVest device exist Review indications for Wearable Cardioverter Defibrillator (WCD) use Give a brief description

More information

Sudden Cardiac Death What an electrophysiologist thinks a cardiologist should know

Sudden Cardiac Death What an electrophysiologist thinks a cardiologist should know Sudden Cardiac Death What an electrophysiologist thinks a cardiologist should know Steven J. Kalbfleisch, M.D. Medical Director Electrophysiology Laboratory Ross Heart Hospital Wexner Medical Center Sudden

More information

Summary, conclusions and future perspectives

Summary, conclusions and future perspectives Summary, conclusions and future perspectives Summary The general introduction (Chapter 1) of this thesis describes aspects of sudden cardiac death (SCD), ventricular arrhythmias, substrates for ventricular

More information

Sudden cardiac arrest How can we improve results of resuscitation?

Sudden cardiac arrest How can we improve results of resuscitation? Sudden cardiac arrest How can we improve results of resuscitation? 127 Applied Cardiopulmonary Pathophysiology 16: 127-132, 2012 Sudden cardiac arrest How can we improve results of resuscitation? Hein

More information

The implantable cardioverter defibrillator is not enough: Ventricular Tachycardia Catheter Ablation in Patients with Structural Heart Disease

The implantable cardioverter defibrillator is not enough: Ventricular Tachycardia Catheter Ablation in Patients with Structural Heart Disease The implantable cardioverter defibrillator is not enough: Ventricular Tachycardia Catheter Ablation in Patients with Structural Heart Disease Paolo Della Bella, MD Arrhythmia Department and Clinical Electrophysiology

More information

Since 1995, the American Heart Association (AHA) has. AHA Science Advisory

Since 1995, the American Heart Association (AHA) has. AHA Science Advisory AHA Science Advisory Lay Rescuer Automated External Defibrillator ( Public Access Defibrillation ) Programs Lessons Learned From an International Multicenter Trial Advisory Statement From the American

More information

Journal of the American College of Cardiology Vol. 47, No. 6, by the American College of Cardiology Foundation ISSN /06/$32.

Journal of the American College of Cardiology Vol. 47, No. 6, by the American College of Cardiology Foundation ISSN /06/$32. Journal of the American College of Cardiology Vol. 47, No. 6, 2006 2006 by the American College of Cardiology Foundation ISSN 0735-1097/06/$32.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2005.11.045

More information

Update on Sudden Cardiac Death and Resuscitation

Update on Sudden Cardiac Death and Resuscitation Update on Sudden Cardiac Death and Resuscitation Ashish R. Panchal, MD, PhD Medical Director Center for Emergency Medical Services Assistant Professor Clinical Department of Emergency Medicine The Ohio

More information

Causes of nonischemic sudden cardiac death in the current era

Causes of nonischemic sudden cardiac death in the current era Causes of nonischemic sudden cardiac death in the current era Eeva Hookana, MSc,* M. Juhani Junttila, MD, Veli-Pekka Puurunen, BM,* Jani T. Tikkanen, BM,* Kari S. Kaikkonen, MD,* Marja-Leena Kortelainen,

More information

Effects of Kidney Disease on Cardiovascular Morbidity and Mortality

Effects of Kidney Disease on Cardiovascular Morbidity and Mortality Effects of Kidney Disease on Cardiovascular Morbidity and Mortality Joachim H. Ix, MD, MAS Assistant Professor in Residence Division of Nephrology University of California San Diego, and Veterans Affairs

More information

Asymptomatic Atrial Fibrillation: Detection and Management. 18 December nd Annual Advances in Heart Disease Palace Hotel, San Francisco

Asymptomatic Atrial Fibrillation: Detection and Management. 18 December nd Annual Advances in Heart Disease Palace Hotel, San Francisco Asymptomatic Atrial Fibrillation: Detection and Management 18 December 2015 32 nd Annual Advances in Heart Disease Palace Hotel, San Francisco Zian H. Tseng, M.D., M.A.S. Associate Professor of Medicine

More information

Update on Sudden Cardiac Death and Resuscitation

Update on Sudden Cardiac Death and Resuscitation Update on Sudden Cardiac Death and Resuscitation Ashish R. Panchal, MD, PhD Medical Director Center for Emergency Medical Services Assistant Professor Clinical Department of Emergency Medicine The Ohio

More information

Incidence of and Survival from Sudden Cardiac Arrest

Incidence of and Survival from Sudden Cardiac Arrest Incidence of and Survival from Sudden Cardiac Arrest Vincent N Mosesso, Jr, MD Professor of Emergency Medicine University of Pittsburgh School of Medicine Disclosures Employer: University of Pittsburgh

More information

Preventing Sudden Death Current & Future Role of ICD Therapy

Preventing Sudden Death Current & Future Role of ICD Therapy Preventing Sudden Death Current & Future Role of ICD Therapy Derek V Exner, MD, MPH, FRCPC, FACC, FAHA, FHRS Professor, Libin Cardiovascular Institute of Alberta Canada Research Chair, Cardiovascular Clinical

More information

Noninvasive Predictors of Sudden Cardiac Death

Noninvasive Predictors of Sudden Cardiac Death 2011 년순환기관련학회춘계통합학술대회 Noninvasive Predictors of Sudden Cardiac Death 영남대학교의과대학순환기내과학교실신동구 Diseases associated with SCD Previous SCD event Prior episode of ventricular tachyarrhythmia Previous myocardial

More information

Primary prevention ICD recipients: the need for defibrillator back-up after an event-free first battery service-life

Primary prevention ICD recipients: the need for defibrillator back-up after an event-free first battery service-life Chapter 3 Primary prevention ICD recipients: the need for defibrillator back-up after an event-free first battery service-life Guido H. van Welsenes, MS, Johannes B. van Rees, MD, Joep Thijssen, MD, Serge

More information

JSC «Astana Medical University» PhD THESIS ANNOTATION. Specialty: 6D «MEDICINE»

JSC «Astana Medical University» PhD THESIS ANNOTATION. Specialty: 6D «MEDICINE» JSC «Astana Medical University» PhD THESIS ANNOTATION Specialty: 6D110100 «MEDICINE» Title: «Prognostic efficiency of sudden cardiac death s predictors in preserved and moderately reduced left ventricle

More information

Who does not need a primary preventive ICD?

Who does not need a primary preventive ICD? Who does not need a primary preventive ICD? Hildegard Tanner, Bern Universitätsklinik für Kardiologie Disclosure of potential conflicts of interest Travel grants for educational purposes from: Biosense

More information

HF and CRT: CRT-P versus CRT-D

HF and CRT: CRT-P versus CRT-D HF and CRT: CRT-P versus CRT-D Andrew E. Epstein, MD Professor of Medicine, Cardiovascular Division University of Pennsylvania Chief, Cardiology Section Philadelphia VA Medical Center Philadelphia, PA

More information

Do All Patients With An ICD Indication Need A BiV Pacing Device?

Do All Patients With An ICD Indication Need A BiV Pacing Device? Do All Patients With An ICD Indication Need A BiV Pacing Device? Muhammad A. Hammouda, MD Electrophysiology Laboratory Department of Critical Care Medicine Cairo University Etiology and Pathophysiology

More information

Risk of sudden cardiac death. Original Article

Risk of sudden cardiac death. Original Article Risk of sudden cardiac death Roxana Sadeghi (1), Nadia Adnani (2), Mohammad-Reza Sohrabi (3), Saeed Alipour Parsa (1) Abstract Original Article BACKGROUND: The aim of this study was to determine characteristics

More information

Sudden Cardiac Arrest

Sudden Cardiac Arrest Sudden Cardiac Arrest Amit Sharma, MD, FACP, FACC Interventional Cardiologist Rockledge Regional Medical Center Assistant Professor of Medicine University of Central Florida Disclosures No relevant financial

More information

Disclosures (2013 to the present)

Disclosures (2013 to the present) What level and types of CV safety data acquisition should be considered to sufficiently characterize a drug s benefit/risk assessment by the end of Phase 3 development? Cardiac Safety Research Consortium

More information

Cardiac Devices CRT,ICD: Who is and is not a Candidate? Who Decides

Cardiac Devices CRT,ICD: Who is and is not a Candidate? Who Decides Cardiac Devices CRT,ICD: Who is and is not a Candidate? Who Decides Colette Seifer MB(Hons) FRCP(UK) Associate Professor, University of Manitoba, Cardiologist, Cardiac Sciences Program, St Boniface Hospital

More information

ICD. Guidelines and Critical Review of Trials. Win K. Shen, MD Professor of Medicine Mayo Clinic College of Medicine Mayo Clinic Arizona Torino 2011

ICD. Guidelines and Critical Review of Trials. Win K. Shen, MD Professor of Medicine Mayo Clinic College of Medicine Mayo Clinic Arizona Torino 2011 ICD Guidelines and Critical Review of Trials Win K. Shen, MD Professor of Medicine Mayo Clinic College of Medicine Mayo Clinic Arizona Torino 2011 Disclosure Relevant Financial Relationship(s) None Off

More information

Biomarkers and Arrhythmias/Devices Ulrika Birgersdotter-Green, M.D.

Biomarkers and Arrhythmias/Devices Ulrika Birgersdotter-Green, M.D. Biomarkers and Arrhythmias/Devices Ulrika Birgersdotter-Green, M.D. Professor of Medicine Division of Cardiology University of California, San Diego Disclosures Honoraria, Research Grants, Medtronic Honoraria,

More information

WPW: Background 10/23/10. Asymptomatic Subjects with WPW Should Undergo Catheter Ablation:! Proponent

WPW: Background 10/23/10. Asymptomatic Subjects with WPW Should Undergo Catheter Ablation:! Proponent Asymptomatic Subjects with WPW Should Undergo Catheter Ablation:! Proponent Ronn E. Tanel, MD Director, Pediatric Arrhythmia Center Associate Professor of Pediatrics UCSF School of Medicine WPW: Background

More information

ICD Therapy. Disclaimers

ICD Therapy. Disclaimers ICD Therapy Rodney Horton, MD Texas Cardiac Arrhythmia Institute Texas Cardiovascular, PA Austin, TX Speaker s Bureau St. Jude Medical Medtronic Boston Scientific Disclaimers Clinical Advisory Panel St.

More information

Sudden Cardiac Arrest and Death in United States Marathons

Sudden Cardiac Arrest and Death in United States Marathons Sudden Cardiac Arrest and Death in United States Marathons David Webner, Kevin M. Duprey, Jonathan A. Drezner, Peter Cronholm, William O. Roberts Oct 24, 2012 Med Sci Sports Exerc. 2012;44(10):1843-1845.

More information

Clinical aspects of Arrhythmogenic Cardiomyopathies

Clinical aspects of Arrhythmogenic Cardiomyopathies Clinical aspects of Arrhythmogenic Cardiomyopathies INTERNATIONAL CLINICAL CARDIOVASCULAR GENETICS CONFERENCE 25 May 2018 Dr Hari Raju MBChB PhD ECES FRACP Clinical Associate Professor, Macquarie University,

More information

Consensus Paper on Out-of-Hospital Cardiac Arrest in England

Consensus Paper on Out-of-Hospital Cardiac Arrest in England Consensus Paper on Out-of-Hospital Cardiac Arrest in England Date: 16 th October 2014 Revision Date: 16 th October 2015 Introduction The purpose of this paper is to bring some clarity to the analysis of

More information

Ethnic Differences in Sudden Cardiac Arrest. Joanna Ghobrial. A Thesis submitted in partial fulfillment of the requirements for the degree of

Ethnic Differences in Sudden Cardiac Arrest. Joanna Ghobrial. A Thesis submitted in partial fulfillment of the requirements for the degree of Ethnic Differences in Sudden Cardiac Arrest Joanna Ghobrial A Thesis submitted in partial fulfillment of the requirements for the degree of Master of Science University of Washington 2014 Committee: Susan

More information

Epidemiology and clinical aspects of sudden cardiac death in the young van der Werf, C.

Epidemiology and clinical aspects of sudden cardiac death in the young van der Werf, C. UvA-DARE (Digital Academic Repository) Epidemiology and clinical aspects of sudden cardiac death in the young van der Werf, C. Link to publication Citation for published version (APA): van der Werf, C.

More information

Clinical and Economic Value of Rivaroxaban in Coronary Artery Disease

Clinical and Economic Value of Rivaroxaban in Coronary Artery Disease CHRISTOPHER B. GRANGER, MD Professor of Medicine Division of Cardiology, Department of Medicine; Director, Cardiac Care Unit Duke University Medical Center, Durham, NC Clinical and Economic Value of Rivaroxaban

More information

Interpretation and Consequences of Repolarisation Changes in Athletes

Interpretation and Consequences of Repolarisation Changes in Athletes Interpretation and Consequences of Repolarisation Changes in Athletes Professor Sanjay Sharma E-mail sasharma@sgul.ac.uk @SSharmacardio Disclosures: None Athlete s ECG Vagotonia Sinus bradycardia Sinus

More information

Secondary prevention of sudden cardiac death

Secondary prevention of sudden cardiac death Secondary prevention of sudden cardiac death Balbir Singh, MD, DM; Lakshmi N. Kottu, MBBS, Dip Card, PGPCard Department of Cardiology, Medanta Medcity Hospital, Gurgaon, India Abstract All randomised secondary

More information

Preoperative Cardiac Evaluation:

Preoperative Cardiac Evaluation: Preoperative Cardiac Evaluation: The New Guidelines Hugo Quinny Cheng, MD Division of Hospital Medicine University of California, San Francisco Disclosures No financial relationships with pharmaceutical

More information

Asymptomatic WPW Syndrome; Observation or Ablation? 전남대학교병원순환기내과 박형욱

Asymptomatic WPW Syndrome; Observation or Ablation? 전남대학교병원순환기내과 박형욱 Asymptomatic WPW Syndrome; Observation or Ablation? 전남대학교병원순환기내과 박형욱 Let It Be? Vs. Just Do It? Natural history of asymptomatic WPW Incidence of sudden cardiac death in natural history studies involving

More information

Device Interrogation- Pacemakers, ICD and Loop Recorders. Dulce Obias-Manno, RN, MHSA, CCDS,CEPS, FHRS Device Clinic Coordinator, MHVI

Device Interrogation- Pacemakers, ICD and Loop Recorders. Dulce Obias-Manno, RN, MHSA, CCDS,CEPS, FHRS Device Clinic Coordinator, MHVI Device Interrogation- Pacemakers, ICD and Loop Recorders Dulce Obias-Manno, RN, MHSA, CCDS,CEPS, FHRS Device Clinic Coordinator, MHVI Disclosures Consultant: Medtronic Speaker s Bureau: St. Jude Medical

More information

Prevention of sudden cardiac death: With an emphasis on sudden cardiac death from ventricular arrhythmias

Prevention of sudden cardiac death: With an emphasis on sudden cardiac death from ventricular arrhythmias Prevention of sudden cardiac death: With an emphasis on sudden cardiac death from ventricular arrhythmias The Toronto ACS Summit Toronto, March 1, 2014 Andrew C.T. Ha, MD, MSc, FRCPC Cardiac Electrophysiology

More information

Πρόληψη του ΑΚΘ σε ασθενείς με μη-ισχαιμική μυοκαρδιοπάθεια:

Πρόληψη του ΑΚΘ σε ασθενείς με μη-ισχαιμική μυοκαρδιοπάθεια: Πρόληψη του ΑΚΘ σε ασθενείς με μη-ισχαιμική μυοκαρδιοπάθεια: Νεώτερα δεδομένα στη διαστρωμάτωση κινδύνου Εμμ. Μ. Κανουπάκης MD, PhD, FESC Πανεπιστημιακό Νοσοκομείο Ηρακλείου NIDCM Presence of LV dilatation

More information

Impact of Lifestyle Modification to Reduce Cardiovascular Disease Event Risk of High Risk Patients with Low Levels of HDL C

Impact of Lifestyle Modification to Reduce Cardiovascular Disease Event Risk of High Risk Patients with Low Levels of HDL C Impact of Lifestyle Modification to Reduce Cardiovascular Disease Event Risk of High Risk Patients with Low Levels of HDL C Thomas P. Bersot, M.D., Ph.D. Gladstone Institute of Cardiovascular Disease University

More information

Sudden cardiac death (SCD) is a leading cause of cardiovascular

Sudden cardiac death (SCD) is a leading cause of cardiovascular Smoking, Smoking Cessation, and Risk of Sudden Cardiac Death in Women Roopinder K. Sandhu, MD, MPH; Monik C. Jimenez, ScD; Stephanie E. Chiuve, ScD; Kathryn C. Fitzgerald, MSc; Stacey A. Kenfield, ScD;

More information

Introduction To ACLS,1 18 April 2011 INTRODUCTION TO ACLS

Introduction To ACLS,1 18 April 2011 INTRODUCTION TO ACLS Introduction To ACLS,1 INTRODUCTION TO ACLS EPIDEMIOLOGY In Singapore, every year about 2,400 people suffer from an acute myocardial infarction. Of these about 900 die as a result of sudden cardiac arrest,

More information

Clinical Controversies in Perioperative Medicine

Clinical Controversies in Perioperative Medicine Clinical Controversies in Perioperative Medicine Hugo Quinny Cheng, MD Division of Hospital Medicine University of California, San Francisco Cardiac Evaluation: New Guidelines A 70-y.o. man with progressive

More information

Cardiac MRI: Cardiomyopathy

Cardiac MRI: Cardiomyopathy Cardiac MRI: Cardiomyopathy Laura E. Heyneman, MD I do not have any relevant financial relationships with any commercial interests Cardiac MRI: Cardiomyopathy Laura E. Heyneman, MD Duke University Medical

More information

Disclosures. Advances in Cardiac Electrophysiology. CVA Risk by Type of AF. Outline

Disclosures. Advances in Cardiac Electrophysiology. CVA Risk by Type of AF. Outline Disclosures Advances in Cardiac Electrophysiology Research Grant: NIH KL2 RR2413 Honoraria (minor): Biotronik St. Jude Medical Advances in Internal Medicine UCSF Department of Medicine, School of Medicine

More information

Management of Syncope in Heart Failure. University of Iowa

Management of Syncope in Heart Failure. University of Iowa Management of Syncope in Heart Failure Brian Olshansky University of Iowa 1 Syncope Transient loss of consciousness, with rapid, usually complete, recovery, with or without prodrome A common, non-specific,

More information

Sudden Cardiac Death in Sports: Causes and Current Screening Recommendations

Sudden Cardiac Death in Sports: Causes and Current Screening Recommendations Sports Cardiology Sudden Cardiac Death in Sports: Causes and Current Screening Recommendations Domenico Corrado, MD, PhD Inherited Arrhytmogenic Cardiomyopathy Unit Department of Cardiac, Thoracic and

More information

Vest Prevention of Early Sudden Death Trial (VEST)

Vest Prevention of Early Sudden Death Trial (VEST) ACC Late Breaking Clinical Trials 2018 Vest Prevention of Early Sudden Death Trial (VEST) Jeffrey Olgin, MD, FACC Division of Cardiology, UCSF On behalf of the VEST Investigators Disclosures ClinicalTrials.gov

More information

Out-Of-Hospital Management and Outcomes of Sudden Cardiac Death Abdelouahab BELLOU, MD, PhD

Out-Of-Hospital Management and Outcomes of Sudden Cardiac Death Abdelouahab BELLOU, MD, PhD Out-Of-Hospital Management and Outcomes of Sudden Cardiac Death Abdelouahab BELLOU, MD, PhD Professor of Internal Medicine, Emergency Medicine, Therapeutics. Past President of the European Society for

More information

Sudden Death in Athletes: Is Screening Justified? Jacob Tfelt-Hansen MD DMSc. Associate Professor and Head of inherited Arrhythmia

Sudden Death in Athletes: Is Screening Justified? Jacob Tfelt-Hansen MD DMSc. Associate Professor and Head of inherited Arrhythmia Sudden Death in Athletes: Is Screening Justified? Jacob Tfelt-Hansen MD DMSc. Associate Professor and Head of inherited Arrhythmia Department of Cardiology, B 2142 Copenhagen University Hospital, Rigshospitalet,

More information

Hot Topics in Cardiac Arrest. Should the patient go To the Cath Lab?

Hot Topics in Cardiac Arrest. Should the patient go To the Cath Lab? Hot Topics in Cardiac Arrest Should the patient go To the Cath Lab? Tim Russert 1950-2008 Host of NBC s Meet the Press Sudden Cardiac Arrest : Autopsy showed plaque rupture in his LAD ( per LA Times,

More information

EHRA/EUROPACE 2011 Madrid, Spain June

EHRA/EUROPACE 2011 Madrid, Spain June EHRA/EUROPACE 2011 Madrid, Spain June 26.-29.2011 Implementing modern management in atrial fibrillation patients Proceedings from the 3rd AFNet/EHRA consensus conference EHRA Special Session Different

More information

Ventricular tachycardia and ischemia. Martin Jan Schalij Department of Cardiology Leiden University Medical Center

Ventricular tachycardia and ischemia. Martin Jan Schalij Department of Cardiology Leiden University Medical Center Ventricular tachycardia and ischemia Martin Jan Schalij Department of Cardiology Leiden University Medical Center Disclosure: Research grants from: Boston Scientific Medtronic Biotronik Sudden Cardiac

More information

Where Does the Wearable Cardioverter Defibrillator (WCD) Fit In?

Where Does the Wearable Cardioverter Defibrillator (WCD) Fit In? Where Does the Wearable Cardioverter Defibrillator (WCD) Fit In? 24 th Annual San Diego Heart Failure Symposium June 1-2, 2018 La Jolla, CA Barry Greenberg, MD Distinguished Professor of Medicine Director,

More information

Advanced MR Imaging in Myocarditis

Advanced MR Imaging in Myocarditis Naeem Merchant MD FRCP Professor of Medicine Department of Radiology Department of Cardiac Sciences Cumming School of Medicine University of Calgary Advanced MR Imaging in Myocarditis The Lake Louise Criteria

More information

WPW in Athletes Should we treat all? age? RAMI FOGELMAN SCHNEIDER CHILDREN MEDICAL CENTER OF ISRAEL

WPW in Athletes Should we treat all? age? RAMI FOGELMAN SCHNEIDER CHILDREN MEDICAL CENTER OF ISRAEL WPW in Athletes Should we treat all? age? RAMI FOGELMAN SCHNEIDER CHILDREN MEDICAL CENTER OF ISRAEL W.P.W Clues in sinus rhythm No Q in Lt chest leads (WPW 88%, control 5%) PR < 100msec (WPW 80%, control

More information

Atrial Fibrillation: Rate vs. Rhythm. Michael Curley, MD Cardiac Electrophysiology

Atrial Fibrillation: Rate vs. Rhythm. Michael Curley, MD Cardiac Electrophysiology Atrial Fibrillation: Rate vs. Rhythm Michael Curley, MD Cardiac Electrophysiology I have no relevant financial disclosures pertaining to this topic. A Fib Epidemiology #1 Most common heart rhythm disturbance

More information

Methods Study population The design and objectives of CHS have been described elsewhere. 9 The CHS is a longitudinal study of 5,888 men

Methods Study population The design and objectives of CHS have been described elsewhere. 9 The CHS is a longitudinal study of 5,888 men N-terminal pro-b-type natriuretic peptide is associated with sudden cardiac death risk: the Cardiovascular Health Study Kristen K. Patton, MD,* Nona Sotoodehnia, MD,* Christopher DeFilippi, MD, FACC, David

More information

Sudden Cardiac Death in Heart Failure: What do we need to know in 2018? Juan M. Aranda, Jr. MD FACC

Sudden Cardiac Death in Heart Failure: What do we need to know in 2018? Juan M. Aranda, Jr. MD FACC Sudden Cardiac Death in Heart Failure: What do we need to know in 2018? Juan M. Aranda, Jr. MD FACC Professor of Medicine Director of Heart Failure and Cardiac Transplantation University of Florida Disclosures

More information

Culprit PCI vs MultiVessel PCI for Acute Myocardial Infarction

Culprit PCI vs MultiVessel PCI for Acute Myocardial Infarction Culprit PCI vs MultiVessel PCI for Acute Myocardial Infarction Dipti Itchhaporia, MD, FACC, FESC Trustee, American College of Cardiology Director of Disease Management, Hoag Hospital Robert and Georgia

More information

Myocardial Injury after Noncardiac Surgery (MINS): What is it and what can we do to help patients suffering this event? PJ Devereaux, MD, PhD

Myocardial Injury after Noncardiac Surgery (MINS): What is it and what can we do to help patients suffering this event? PJ Devereaux, MD, PhD Myocardial Injury after Noncardiac Surgery (MINS): What is it and what can we do to help patients suffering this event? PJ Devereaux, MD, PhD Disclosure Member of research group with policy of not accepting

More information

FANS Paediatric Pathway for Inherited Arrhythmias*

FANS Paediatric Pathway for Inherited Arrhythmias* FANS Paediatric Pathway for Inherited Arrhythmias* The pathway is based on the HRS/EHRA/APHRS Expert Consensus Statement on the Diagnosis and Management of Patients with Inherited Primary Arrhythmia Syndromes

More information

Investigating the family after a sudden cardiac death. Dr Catherine Mercer Consultant Clinical Geneticist, Wessex

Investigating the family after a sudden cardiac death. Dr Catherine Mercer Consultant Clinical Geneticist, Wessex Investigating the family after a sudden cardiac death Dr Catherine Mercer Consultant Clinical Geneticist, Wessex Sudden adult deaths subdivided Sudden Adult Death Sudden Cardiac Death Sudden Arrhythmic

More information

Intraaortic Balloon Counterpulsation- Supportive Data for a Role in Cardiogenic Shock ( Be Still My Friend )

Intraaortic Balloon Counterpulsation- Supportive Data for a Role in Cardiogenic Shock ( Be Still My Friend ) Intraaortic Balloon Counterpulsation- Supportive Data for a Role in Cardiogenic Shock ( Be Still My Friend ) Stephen G. Ellis, MD Section Head, Interventional Cardiology Professor of Medicine Cleveland

More information

Treatment of Arrhythmias in the Emergency Setting

Treatment of Arrhythmias in the Emergency Setting Treatment of Arrhythmias in the Emergency Setting Zian H. Tseng, M.D. Assistant Professor of Medicine Cardiac Electrophysiology Section Cardiology Division University of California, San Francisco There

More information

SCREENING AND PREVENTING SUDDEN CARDIAC DEATH IN EXERCISE

SCREENING AND PREVENTING SUDDEN CARDIAC DEATH IN EXERCISE SCREENING AND PREVENTING SUDDEN CARDIAC DEATH IN EXERCISE Adj Assc Prof Tong Khim Leng MBBS MRCP FACC FASE FAMS FRCP Chief, Sn Consultant Department of Cardiology Changi General Hospital My Disclosures

More information

Prevention of Sudden Death in ARVC

Prevention of Sudden Death in ARVC ESC Munich, August 29, 2012 Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC): Prevention of Sudden Death in ARVC Thomas Wichter, MD, FESC Professor of Medicine - Cardiology Marienhospital Osnabrück

More information

Endpoints When Treating VT/VF in Patients with ICDs Programming Wojciech Zareba, MD, PhD

Endpoints When Treating VT/VF in Patients with ICDs Programming Wojciech Zareba, MD, PhD Endpoints When Treating VT/VF in Patients with ICDs Programming Wojciech Zareba, MD, PhD Professor of Cardiology/Medicine Director of the Heart Research Follow Up Program, University of Rochester, Rochester,

More information

Primary Therapy for High Risk LQT Patients Should Be an ICD

Primary Therapy for High Risk LQT Patients Should Be an ICD Primary Therapy for High Risk LQT Patients Should Be an ICD Raul Weiss MD, FAHA, FACC, FHRS, CCDS Director, Electrophysiology Fellowship Program Associate Professor of Medicine The Ohio State University

More information

The 5 Most Important Things You Need to Know About Atrial Fibrillation. John D. Day, MD

The 5 Most Important Things You Need to Know About Atrial Fibrillation. John D. Day, MD The 5 Most Important Things You Need to Know About Atrial Fibrillation John D. Day, MD Disclosures Consulting with St. Jude Medical, Boston Scientific, and Biotronik The 5 Most Important Things You Need

More information

Johnson County Emergency Medical Services Page 23

Johnson County Emergency Medical Services Page 23 Non-resuscitation Situations: Resuscitation should not be initiated in the following situations: Prolonged arrest as evidenced by lividity in dependent parts, rigor mortis, tissue decomposition, or generalized

More information

Sports Cardiology: Matters of the Heart. AMSSM Exchange Lecture AOSSM 2013 Annual Meeting

Sports Cardiology: Matters of the Heart. AMSSM Exchange Lecture AOSSM 2013 Annual Meeting Sports Cardiology: Matters of the Heart AMSSM Exchange Lecture AOSSM 2013 Annual Meeting Matthew Gammons, MD Vermont Orthopaedic Clinic Killington Medical Clinic Although sudden cardiac death is a relatively

More information

HIP ATTACK Trial: Can we improve outcomes after a hip fracture with accelerated surgery? PJ Devereaux, MD, PhD

HIP ATTACK Trial: Can we improve outcomes after a hip fracture with accelerated surgery? PJ Devereaux, MD, PhD HIP ATTACK Trial: Can we improve outcomes after a hip fracture with accelerated surgery? PJ Devereaux, MD, PhD Disclosure Member of research group with policy of not accepting honorariums or other payments

More information

Supplementary material 1. Definitions of study endpoints (extracted from the Endpoint Validation Committee Charter) 1.

Supplementary material 1. Definitions of study endpoints (extracted from the Endpoint Validation Committee Charter) 1. Rationale, design, and baseline characteristics of the SIGNIFY trial: a randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease without clinical

More information

NEWLY DETECTED ATRIAL FIBRILLATION. Edgar S. Carell, M.D. Director, Vascular Medicine Clinic West Suburban Cardiology

NEWLY DETECTED ATRIAL FIBRILLATION. Edgar S. Carell, M.D. Director, Vascular Medicine Clinic West Suburban Cardiology NEWLY DETECTED ATRIAL FIBRILLATION Edgar S. Carell, M.D. Director, Vascular Medicine Clinic West Suburban Cardiology 68 y/o woman complains of - generalized fatigue - mild DOE - never eats but keeps gaining

More information

TENNESSEE Project ADAM. Preventing Sudden Cardiac Death (SCD): Implementing your school s Public Access to Defibrillation (PAD) program.

TENNESSEE Project ADAM. Preventing Sudden Cardiac Death (SCD): Implementing your school s Public Access to Defibrillation (PAD) program. TENNESSEE Project ADAM Preventing Sudden Cardiac Death (SCD): Implementing your school s Public Access to Defibrillation (PAD) program. In Tennessee IT S THE LAW. All schools equipped with an AED must

More information

Chapter 4: Cardiovascular Disease in Patients With CKD

Chapter 4: Cardiovascular Disease in Patients With CKD Chapter 4: Cardiovascular Disease in Patients With CKD Introduction Cardiovascular disease is an important comorbidity for patients with chronic kidney disease (CKD). CKD patients are at high-risk for

More information

EVALUATION OF THE ATHLETE. Karen Stout, MD Professor, Medicine and Pediatrics University of Washington

EVALUATION OF THE ATHLETE. Karen Stout, MD Professor, Medicine and Pediatrics University of Washington EVALUATION OF THE 12 ATHLETE Karen Stout, MD Professor, Medicine and Pediatrics University of Washington NO DISCLOSURES OUTLINE Why evaluate athletes? What s the problem? What evaluation should be done?

More information

Arthur J. Moss, MD Professor of Medicine/Cardiology University of Rochester Medical Center Rochester, NY. DISCLOSURE INFORMATION Arthur J.

Arthur J. Moss, MD Professor of Medicine/Cardiology University of Rochester Medical Center Rochester, NY. DISCLOSURE INFORMATION Arthur J. Saving Lives and Preventing Heart Failure: The MADIT Family of Trials Arthur J. Moss, MD Professor of Medicine/Cardiology University of Rochester Medical Center Rochester, NY Update in Electrocardiography

More information

Clinical Controversies in Perioperative Medicine

Clinical Controversies in Perioperative Medicine Update on Perioperative Medicine Clinical Controversies in Perioperative Medicine Hugo Quinny Cheng, MD Division of Hospital Medicine University of California, San Francisco Cardiac Medications & Perioperative

More information

Assessment of Defibrillation Threshold upon Implantable Cardioverter-Defibrillator implant in Relation to patient s prognosis

Assessment of Defibrillation Threshold upon Implantable Cardioverter-Defibrillator implant in Relation to patient s prognosis Assessment of Defibrillation Threshold upon Implantable Cardioverter-Defibrillator implant in Relation to patient s prognosis Investigator: Keiko Saito, MD Mentor: Yuji Saito, MD, PhD, FACP, FACC Department

More information

CARDIOLOGY GRAND ROUNDS

CARDIOLOGY GRAND ROUNDS CARDIOLOGY GRAND ROUNDS Presentation: Date: Location: Speaker: ACC 2015 PREVIEW Monday, March 9, 2015, 7:00 8:00 AM ANW Education Building, Watson Room Elevated Troponin in Patients Presenting to the Emergency

More information

2017 AHA/ACC/HRS Ventricular Arrhythmias and Sudden Cardiac Death Guideline. Top Ten Messages. Eleftherios M Kallergis, MD, PhD, FESC

2017 AHA/ACC/HRS Ventricular Arrhythmias and Sudden Cardiac Death Guideline. Top Ten Messages. Eleftherios M Kallergis, MD, PhD, FESC 2017 AHA/ACC/HRS Ventricular Arrhythmias and Sudden Cardiac Death Guideline Top Ten Messages Eleftherios M Kallergis, MD, PhD, FESC Cadiology Department - Heraklion University Hospital No actual or potential

More information